GLOW blend in Canada

GLOW blend is a three-peptide research blend: a copper tripeptide, a gastric pentadecapeptide and a thymosin beta-4 related peptide, and that classification is where the published work starts. The published work on it is in rat, human, mouse and cell culture. Borealis Peptides supplies it as lyophilised powder in 70 mg vials for in-vitro laboratory research. It is not authorized as a medicine and is not for use in any living subject. Every reference here is listed with the model it ran in and the finding as published.

Direct from Borealis Peptides, held in Canadian stock so nothing crosses a border on its way to you. Stocked in 70 mg vials. Purity is confirmed by HPLC batch by batch, and we supply for laboratory research only. Identity and purity are checked per batch, and the paperwork names that batch specifically.

Canada has no authorized GLOW blend product: no DIN has been issued for it. That means Health Canada has not assessed it for safety, efficacy or quality. It is stocked here as laboratory research material and for no use in a person or an animal. Health Canada has said that "Research Use Only" labelling does not make a product legal to use in a person, so we treat it as a description of what the material is supplied for rather than a permission.

We do not answer dosing questions. GLOW blend is not supplied for use in a person or an animal, so there is no dose to describe. What this page carries is the amount each cited study used and the model it used it in, reproduced as the authors published it.

Of the 8 studies cited, one is a controlled trial in people and the rest are animal or cell work. Each row names its model, the amount used and what the authors reported, so the weight of each study can be judged directly rather than through a summary.

Sealed vials are held at −20 °C, dry and out of the light. Once reconstituted, 2–8 °C. Because the dry form is stable at room temperature, shipping needs no cold chain; refrigerate it when it arrives. Light and repeated warming do more damage than the journey.

Every batch is tested by HPLC before it is sold, and the certificate refers to the batch in your vial rather than to the product in general. Keeping that batch number with your records is what makes an observation reproducible later. Certificates are available on request.

Each has its own published record, and comparing them is a matter of reading both. GHK-Cu and KLOW have 8 cited studies and 8 cited studies on their page against 8 here. What separates them is the published work, which both pages set out in full.

Because it was among the peptides seized from sellers offering unauthorized injectable products online. The advisory concerns material sold for people to inject without authorization. Borealis Peptides supplies research material for laboratory use and sells nothing for injection or for any use in a person, which is the line that advisory draws.